12 Participants Needed

Video Program for Alzheimer's Disease

(RT-D ADRD Trial)

SM
SM
Overseen BySydney M McCage, MA
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: Icahn School of Medicine at Mount Sinai
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Resilient Together for Dementia (RT-D, RT-ADRD) for Alzheimer's Disease?

The RDAD program, which is similar to Resilient Together for Dementia, has been effective in teaching caregivers strategies to improve mood, behavior, and physical function in people with dementia. This suggests that similar approaches, like Resilient Together for Dementia, may also be beneficial.12345

What makes the Resilient Together for Dementia treatment unique compared to other treatments for Alzheimer's disease?

The Resilient Together for Dementia treatment is unique because it combines video programs designed to engage and calm individuals with dementia, providing caregivers with respite time, and involves caregivers in exercise activities to improve mood and behavior, which is different from traditional medication-based treatments.12367

What is the purpose of this trial?

The proposed study will establish the feasibility, acceptability and credibility of a novel live video dyadic resiliency intervention, Resilient Together for Dementia (RT-D), aimed at preventing chronic emotional distress and preserving quality of life among dyads at risk for chronic emotional distress early after a diagnosis of Alzheimer's disease or a related dementia (ADRD).

Research Team

SB

Sarah Bannon

Principal Investigator

Icahn School of Medicine at Mount Sinai

Eligibility Criteria

This trial is for pairs (dyads) where one person has early-stage Alzheimer's or related dementia and the other is a caregiver. They should be at risk of chronic emotional distress. Specific eligibility details are not provided, but typically there would be criteria around age, health status, and ability to participate in video sessions.

Inclusion Criteria

Dyad lives together
At least one partner endorses clinically significant emotional distress during screening (>7 on Hospital Anxiety and Depression scale subscales)
I was diagnosed with Alzheimer's or dementia about a month ago.
See 4 more

Exclusion Criteria

Patient is deemed inappropriate by the neurology team
Either partner has a co-occurring terminal illness
Patient was diagnosed with forms of dementia with clinical profiles that would preclude participation (e.g., Frontotemporal Dementia- behavioral variant), as determined by treatment team

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1.5-2 months

Treatment

Participants receive the Resilient Together for Dementia intervention via live video sessions

6 weeks
Weekly live video sessions

Follow-up

Participants are monitored for changes in emotional distress using the Hospital Anxiety and Depression Scale

4 weeks

Treatment Details

Interventions

  • Resilient Together for Dementia
Trial Overview The study tests 'Resilient Together for Dementia', a live video intervention designed to help both the patient with dementia and their caregiver manage emotional stress and maintain quality of life after diagnosis.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Open Pilot RT-D DyadsExperimental Treatment1 Intervention
Persons living with dementia (PWDs) and their spousal care-partners

Find a Clinic Near You

Who Is Running the Clinical Trial?

Icahn School of Medicine at Mount Sinai

Lead Sponsor

Trials
933
Recruited
579,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

The RDAD program effectively teaches caregivers strategies to enhance mood, behavior, and physical function in individuals with dementia, and has been successfully adapted for use by Area Agencies on Aging in Washington and Oregon.
Modifications to the RDAD program included reducing in-person sessions while maintaining educational content and involving caregivers in exercise activities, demonstrating its flexibility and applicability to a diverse range of cognitive impairments and caregiving situations.
Training Area Agencies on Aging Case Managers to Improve Physical Function, Mood, and Behavior in Persons With Dementia and Caregivers: Examples from the RDAD-Northwest Study.McCurry, SM., Logsdon, RG., Pike, KC., et al.[2019]
The updated Dementia Dialogues® program significantly increased caregiver knowledge about Alzheimer's disease and related dementias, as shown by a study of 235 participants from North and South Carolina.
Caregivers showed greater knowledge improvement compared to noncaregivers, indicating that the program effectively educates those directly involved in caring for individuals with dementia.
An Evaluation of Dementia Dialogues®: A Program for Informal and Formal Caregivers in North and South Carolina.Byers, MD., Resciniti, NV., Ureña, S., et al.[2022]
With appropriate staff training and orientation, caregivers can better understand and meet the individual needs of advanced dementia patients, enhancing their participation in social and therapeutic activities.
Implementing tailored programs for these patients can improve their quality of life and provide meaningful human contact, even as their cognitive abilities decline.
Working with advanced dementia patients in a day care setting.Abramowitz, L.[2015]

References

Training Area Agencies on Aging Case Managers to Improve Physical Function, Mood, and Behavior in Persons With Dementia and Caregivers: Examples from the RDAD-Northwest Study. [2019]
An Evaluation of Dementia Dialogues®: A Program for Informal and Formal Caregivers in North and South Carolina. [2022]
Working with advanced dementia patients in a day care setting. [2015]
Development of an integrative learning program for community dwelling old people with dementia. [2021]
Design and Development of a Community-Based, Interdisciplinary, Collaborative Dementia Care Program. [2022]
Video Respite: an innovative resource for family, professional caregivers, and persons with dementia. [2019]
Evaluation of Dementia-Friendly Initiatives, Small-Scale Homelike Residential Care, and Dementia Village Models: A Scoping Review. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security